A new study from Columbia University says the omicron variant of COVID-19 is proving to be “markedly resistant” to vaccines.

“A striking feature of this variant is the large number of spike mutations 31 that pose a threat to the efficacy of current COVID-19 vaccines and antibody therapies,” says an abstract from more than 20 scientists with Columbia University and the University of Hong Kong.

Recommended Stories

Moderna requests authorization for COVID-19 vaccine for children under 6

South African hospital data suggest omicron not more lethal

FDA authorizes Pfizer-BioNTech COVID-19 boosters for children 5-11